Bristol-Myers Squibb (BMY) earnings per share (EPS)

Earnings per share · fiscal 2025
$3.46

Bristol-Myers Squibb (BMY) reported diluted earnings per share of $3.46 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$4.41. Figures as of 18 Nov 2026, 00:52 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
$3.46
Growth, 10 years
+14.0% a year
Highest on record
$5.34fiscal 2009
Lowest on record
-$4.41fiscal 2024
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bristol-Myers Squibb earnings per share (EPS), in more detail

Over the ten fiscal years to 2025 diluted earnings per share grew at a compound 14.0% a year. Across the 19 fiscal years on record (2007–2025), the highest was $5.34 in fiscal 2009 and the lowest -$4.41 in fiscal 2024.

History · 19 fiscal years

Earnings per share by fiscal year

Bristol-Myers Squibb earnings per share (EPS), year by year

Bristol-Myers Squibb (BMY) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025$3.46—
2024-$4.41 214.2% down
2023$3.86 30.8% up
2022$2.95 5.4% down
2021$3.12—
2020-$3.99 298.5% down
2019$2.01 33.2% down
2018$3.01 393.4% up
2017$0.61 77.0% down
2016$2.65 184.9% up
2015$0.93 22.5% down
2014$1.20 22.1% down
2013$1.54 32.8% up
2012$1.16 46.3% down
2011$2.16 20.7% up
2010$1.79 66.5% down
2009$5.34 103.8% up
2008$2.62 140.4% up
2007$1.09—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Bristol-Myers Squibb and comparable companies
CompanyEarnings per shareFiscal year
Vertex Pharmaceuticals VRTX$15.322025
Medtronic MDT$3.732026
Bristol-Myers Squibb BMY$3.462025
Stryker SYK$8.402025
McKesson MCK$38.382026
Sanofi SNY€3.202025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BMY

Bristol-Myers Squibb, figure by figure

Bristol-Myers Squibb (BMY) overview: price, valuation and scorecardAll health care companies by market value

Bristol-Myers Squibb earnings per share (EPS): questions and answers

What is Bristol-Myers Squibb's diluted earnings per share?

Bristol-Myers Squibb (BMY) reported diluted earnings per share of $3.46 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$4.41.

What is the growth rate of Bristol-Myers Squibb's diluted earnings per share?

Over the ten fiscal years to 2025 diluted earnings per share grew at a compound 14.0% a year.

What are the highest and lowest diluted earnings per share figures on record for Bristol-Myers Squibb?

Across the 19 fiscal years on record (2007–2025), the highest was $5.34 in fiscal 2009 and the lowest -$4.41 in fiscal 2024.

How is Bristol-Myers Squibb's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bristol-Myers Squibb (BMY) earnings per share (EPS)”, data as of 18 November 2026. https://funkfolio.com/stock/BMY/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.